chr4-169106857-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020870.4(SH3RF1):c.2488G>A(p.Val830Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000122 in 1,554,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020870.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SH3RF1 | NM_020870.4 | c.2488G>A | p.Val830Ile | missense_variant | 11/12 | ENST00000284637.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SH3RF1 | ENST00000284637.14 | c.2488G>A | p.Val830Ile | missense_variant | 11/12 | 1 | NM_020870.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000233 AC: 5AN: 214708Hom.: 0 AF XY: 0.0000171 AC XY: 2AN XY: 117238
GnomAD4 exome AF: 0.0000114 AC: 16AN: 1402458Hom.: 0 Cov.: 31 AF XY: 0.0000101 AC XY: 7AN XY: 691372
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.2488G>A (p.V830I) alteration is located in exon 11 (coding exon 10) of the SH3RF1 gene. This alteration results from a G to A substitution at nucleotide position 2488, causing the valine (V) at amino acid position 830 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at